SCIE期刊CURRENT OPINION IN PHARMACOLOGY 2024/2025影响因子:4.162 (CURR OPIN PHARMACOL) (1471-4892). (PHARMACOLOGY & PHARMACY)(

显示全部楼层 · 发表于 2025-3-25 08:42:04

Submitted on: 08 December 2020. Revised on: 11 January 2021. Accepted on: 11 February 2021. ___________________CURRENT OPINION IN PHARMACOLOGY

显示全部楼层 · 发表于 2025-3-25 15:06:35

显示全部楼层 · 发表于 2025-3-25 16:32:37

Submitted on: 05 March 2012. Revised on: 09 April 2012. Accepted on: 07 May 2012. ___________________CURRENT OPINION IN PHARMACOLOGY

显示全部楼层 · 发表于 2025-3-25 20:36:51

Submitted on: 22 May 2009. Revised on: 17 August 2009. Accepted on: 10 September 2009. ___________________CURRENT OPINION IN PHARMACOLOGY

显示全部楼层 · 发表于 2025-3-26 01:00:48

显示全部楼层 · 发表于 2025-3-26 07:50:41

Submitted on: 11 August 2002. Revised on: 04 September 2002. Accepted on: 23 October 2002. ___________________CURRENT OPINION IN PHARMACOLOGY

显示全部楼层 · 发表于 2025-3-26 08:59:04

显示全部楼层 · 发表于 2025-3-26 14:44:09

显示全部楼层 · 发表于 2025-3-26 19:27:51

Submitted on: 07 June 2012. Revised on: 20 September 2012. Accepted on: 04 November 2012. ___________________CURRENT OPINION IN PHARMACOLOGY

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 16:18
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved